Detalles de la búsqueda
1.
Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD-mutated, relapsed or refractory AML.
Blood
; 132(6): 598-607, 2018 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29875101
2.
Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite.
Br J Clin Pharmacol
; 85(9): 2108-2117, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31173645
3.
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 19(7): 889-903, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29859851
4.
Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant.
Am J Hematol
; 93(2): 222-231, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29090473
5.
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
Ann Surg Oncol
; 24(13): 3991-4000, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29019177
6.
An open-label, single-dose, phase 1 study of the absorption, metabolism and excretion of quizartinib, a highly selective and potent FLT3 tyrosine kinase inhibitor, in healthy male subjects, for the treatment of acute myeloid leukemia.
Xenobiotica
; 47(10): 856-869, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27460866
7.
Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial.
Transplant Cell Ther
; 27(2): 153-162, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33017662
8.
Effect of Food on the Pharmacokinetics of Quizartinib.
Clin Pharmacol Drug Dev
; 9(2): 277-286, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916418
9.
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Clin Cancer Res
; 22(16): 4014-22, 2016 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26920889
10.
Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.
J Clin Oncol
; 20(23): 4549-54, 2002 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12454111
11.
Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.
Clin Cancer Res
; 8(9): 2775-81, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12231516
12.
Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status.
J Clin Oncol
; 31(29): 3681-7, 2013 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24002496
13.
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
Ann Surg
; 236(4): 438-48; discussion 448-9, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12368672
Resultados
1 -
13
de 13
1
Próxima >
>>